Royal Philips has unveiled its plans to integrate its advanced spectral CT imaging technology with a hybrid Angio CT suite to offer a single interventional solution.

The company will combine its Spectral CT 7500 system and Azurion image-guided therapy systems with FlexArm to create the interventional suite.

With the integration, interventionalists will get access to Philips’ two important imaging modalities, and will be able to perform both CT and Angio guidance procedures in one room.

Philips has collaborated with Mayo Clinic and Baptist Health’s Miami Cardiac & Vascular Institute for the development of the integrated solution.

Baptist’s Health Miami cardiac and vascular institute founder and chief medical executive Barry T Katzen said: “There has been a tremendous evolution in the image-guided therapy environment.

“We are really excited about the merger and integration of these technologies in that it might allow us to look at the treatment of a number of diseases in very new and innovative ways, potentially offering new treatment opportunities and improving patient care.”

The integration creates a workflow environment, where all the essential imaging modalities are available, and can be controlled from the patient’s table-side, said Philips.

It is said to allow the interventional team to gain unrestricted access to the patient, as each modality moves smoothly away from the patient table into a parking position when not in use.

The integrated solution provides easy workflows for interventionalists, eliminating the need for moving the patient between imaging suites.

Also, it enables physicians to use both the systems on a patient during a single procedure, as each system can work stand-alone if required.

Philips said that spectral CT has showed superior sensitivity in detecting malignant findings and has delivered improved readings of incidental findings.

Its ‘always-on’ spectral CT technology requires just one scan to capture all the spectral information required to differentiate and quantify different tissues, said the company.

Philips image guided therapy systems general manager Karim Boussebaa said: “With this innovation, we are taking a uniquely patient-centric approach, aimed at bringing the latest interventional imaging modalities to the patient table rather than moving the patient to the individual modalities.

“We are excited to be co-creating the future of image guided therapy with leading clinical partners by combining the best of our award-winning modalities into a single suite.”